Recombinant pox virus containing sequence encoding myelin protein and infected cells for use in inflammatory demyelinizing disease diagnosis, therapy, gene therapy and recombinant vaccine

By  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 757-757

Elsevier

Access to resources Recommend Favorite

Optimization of DNA immunization against human cytomegalovirus

By Endresz V.   Burian K.   Berencsi K.   Gyulai Z.   Kari L.   Horton H.   Virok D.   Meric C.   Plotkin S.A.   Gonczol E.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3972-3980

Elsevier

Access to resources Recommend Favorite

Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4 + T-cell clones in vitro

By Prieur E.   Betbeder D.   Niedergang F.   Major M.   Alcover A.   Davignon J.-L.   Davrinche C.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 511-520

Elsevier

Access to resources Recommend Favorite

Preclinical evaluation of an ALVAC (canarypox)-human cytomegalovirus glycoprotein B vaccine candidate

By Gonczol E.   Berencsi K.   Pincus S.   Endresz V.   Meric C.   Paoletti E.   Plotkin S.A.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1080-1085

Elsevier

Access to resources Recommend Favorite

New modified -human chorionic gonadotropin proteins; HCG protein engineering and expression in a mammal or microorganism cell, for use as a contraceptive and antitumor recombinant vaccine, or a nucleic acid vaccine

By Roitt I.   Delves P.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 935-935

Elsevier

Access to resources Recommend Favorite